
Doxorubicin Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 10 mg/5 mL, 50 mg/25 mL, 200 mg/100 mL (in vials)
Reference Brands: Adriamycin® (EU & US)
Category: Oncology Cancer Care
Doxorubicin is available in Injection and strengths such as 10 mg/5 mL, 50 mg/25 mL, 200 mg/100 mL (in vials). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Doxorubicin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Doxorubicin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Doxorubicin is a potent chemotherapy drug used to treat a wide range of cancers, including breast cancer, leukemia, and lymphomas. As an anthracycline, it works by inhibiting DNA replication in cancer cells, leading to cell death. Available in 10 mg/5 mL, 50 mg/25 mL, and 200 mg/100 mL vial strengths, Doxorubicin is marketed as Adriamycin® in both the US and EU. With its significant role in cancer treatment, it offers substantial B2B opportunities for pharmaceutical companies targeting oncology treatments in these regions.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers